Investigating Alternative Nuclear Reactions for Medical Isotope Production ABSTRACT The array of radionuclides used for, or considered as good candidates for, nuclear medicine has expanded in recent years. Of these radionuclides 44Sc and 67Cu have shown great promise for use in diagnostic and therapeutic applications, respectively. A challenge associated with translating 44Sc and 67Cu from research scale to long-term medical use is the difficulty in producing each of these radionuclides in large quantities. The production limitation is due to the low cross sections (the probability) of the nuclear reactions that create the purist supply of these isotopes. Since production routes using particle beams commonly used for medical isotopes (protons, neutrons, deuterons) do not result in sufficient cross sections, the proposed work aims to investigate employing heavy ion beam reactions. Heavy ion beams, such as 7Li, offer the potential to produce 67Cu and 44Ti (44Ti is the 44Sc parent) at higher cross sections. The proposed research will focus on the measurement of the cross sections for such reactions. Additionally, post irradiation radiochemistry will be performed so that the final purity of the radionuclides can be compared to the current production methods. Successful demonstration of higher production rates with comparable radionuclide purity will offer an additional production route to make these valuable medical isotopes.

Public Health Relevance

/Relevence Statement The radionuclides 44Sc and 67Cu are important to the nuclear medicine community for diagnostic and therapeutic cancer applications, respectively. Preventing these radionuclides from transitioning from laboratory studies to full clinical use is the challenge in producing them in large enough quantities to meet the medical need. The proposed research aims to measure nuclear reaction probabilities for alternative pathways to produce 44Ti (the parent radionuclide to 44Sc) and 67Cu to hopefully identify routes to make enough of these important radionuclides to implement their use clinically.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Pilot Research Project (SC2)
Project #
5SC2GM131975-02
Application #
9937758
Study Section
Special Emphasis Panel (ZGM1)
Program Officer
Krasnova, Irina N
Project Start
2019-06-01
Project End
2022-05-31
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
2
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Hunter College
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
620127915
City
New York
State
NY
Country
United States
Zip Code
10065